Tag: Glaucoma
Lasting Damage After Monolateral Acute Primary Angle Closure
More than half of fellow eyes develop chronic angle closure glaucoma after acute primary angle closure
Education Can Boost Knowledge, Cut Anxiety in Glaucoma
Patient-centered glaucoma-related educational intervention beneficial for newly diagnosed patients
Retinal Ganglion Cell + Inner Plexiform Layer Loss Affects QoL
Glaucoma-related macular RGC+IPL loss linked to vision-related quality of life more than thickness
Cognitive Decline Linked to Visual Field Variability
Decrease in Montreal Cognitive Assessment linked to increased visual field variability over time
GAT Values More Discordant Than DCT Measures in Glaucoma
Goldmann applanation tonometry values for IOP discordant in eyes with thin corneas, glaucoma
ARVO: Latanoprost Halts Myopia Progression in Animal Study
Latanoprost effective for lowering IOP, slowing myopia progression in myopia model
Glaucoma Surgery Risk Up With 7+ Injections of Bevacizumab
Patients who received four to six injections had a nonsignificantly increased risk of glaucoma surgery
Moderate Interobserver Agreement for Glaucoma Software
Moderate agreement for visual field and OCT glaucoma progression software packages
Anterior Segment Parameters Tied to Gonioscopic Angle Closure
Smaller baseline angle opening distance at 750 µm, larger lens vault linked to development of closure
Modest Links for Systemic Medication Use, IOP in Glaucoma
Systemic β-blocker use linked to lower IOP; ACEI, ARB, statin, sulfonylurea linked to higher IOP
